MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation

Core Insights - MindBio Therapeutics Corp. has appointed Felipe Leyton to lead the commercialization of its AI-powered voice analytics technology in the South American mining sector, marking a significant transition from development to commercial deployment [1][2][10] Company Overview - MindBio is a biotechnology company focused on commercializing AI prediction technologies for drug and alcohol impairment detection through voice analysis, utilizing over 50 million data points for accurate predictions [13] Appointment of Felipe Leyton - Felipe Leyton is recognized as a leading authority in drug and alcohol public policy and mining industry safety in South America, having previously implemented Chile's Zero Tolerance framework for alcohol-impaired driving [3][9] - Leyton's role will involve developing mining-specific testing protocols, expanding clinical validation, and overseeing the phased deployment of MindBio's technology in active mining environments [7][4] Technology and Market Opportunity - MindBio's Edge AI hardware-software kiosk system is nearing completion, with field testing scheduled to begin in Q2 2026, representing a major commercial milestone [8] - Substance use is a significant occupational safety risk in heavy industry, with estimates indicating that 20-25% of occupational accidents are linked to substance use globally [9] - In Chile, alcohol consumption among mining workers exceeds 75%, with approximately 40% classified as problem drinkers and 9% reporting drug use, highlighting a substantial market opportunity for real-time impairment detection technologies [11][9]